Az oldal megfelelő megjelenítéséhez engedélyezze böngészőjében a JavaScript használatát!

You are here

Mezei Zoltán András

Mezei Zoltán András

Department of Laboratory Medicine

2011-

Name: Mezei Zoltán András

Other profiles: Google Scholar, MTMT

Publication list

printer-friendly version

Export to MTMT compatible RIS file
Upload publications
Request certified publication list

Uploaded publications:

26

Publications in DEA:

26

OA:

9

Date range:

2012-2024

2024

Baráth, S., Singh, P., Hevessy, Z., Ujfalusi, A., Mezei, Z., Balogh, M., Széles, M., Kappelmayer, J.: Enhancing HLA-B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis.
Cytom. Part B-Clin. Cytom. [Epub ahead of print]2024.

Journal metrics:

Q3 Cell Biology (2023)
Q2 Histology (2023)
Q1 Pathology and Forensic Medicine (2023)

2023

Pethő, Á., Nagy, Z., Mezei, Z., Takács, I., Demeter, J.: Béta-thalassaemia, B12-vitamin-hiány és társuló komplementmediált hemolízis.
Orv. hetil. 164 (24), 954-960, 2023.

Journal metrics:

Q4 Medicine (miscellaneous)

2022

Singh, P., Széles, M., Mezei, Z., Baráth, S., Hevessy, Z.: Age-dependent frequency of unconventional T cells in a healthy adult Caucasian population: a combinational study of invariant natural killer T cells, [gamma][delta] T cells, and mucosa-associated invariant T cells.
GeroScience. 44 (4), 2047-2060, 2022.

Journal metrics:

Q1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
Q1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
Baráth, S., Mezei, Z., Széles, M., Hevessy, Z.: Combined use of different antibody clones improves the efficiency of human leukocyte antigen B27 detection by flow cytometry.
Cytom. Part B-Clin. Cytom. 102 (3), 239-245, 2022.

Journal metrics:

Q2 Cell Biology
Q1 Histology
Q1 Pathology and Forensic Medicine
Singh, P., Széles, M., Mezei, Z., Baráth, S., Hevessy, Z.: Gender-dependent frequency of unconventional T cells in a healthy adult Caucasian population: a combinational study of invariant NKT cells, [gamma] [delta] T cells, and mucosa-associated invariant T cells.
J. Leukoc. Biol. 112 (5), 1155-1165, 2022.

Journal metrics:

Q1 Cell Biology
Q1 Immunology
Q1 Immunology and Allergy

2021

Bereczky, Z., Gindele, R., Fiatal, S., Speker, M., Miklós, T., Balogh, L., Mezei, Z., Szabó, Z., Ádány, R.: Age and Origin of the Founder Antithrombin Budapest 3 (p.Leu131Phe) Mutation; Its High Prevalence in the Roma Population and Its Association With Cardiovascular Diseases.
Front. Cardiovasc. Med. 7 1-15, 2021.

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine
Koczok, K., Horváth, L., Korade, Z., Mezei, Z., P. Szabó, G., Porter, N., Kovács, E., Mirnics, K., Balogh, I.: Biochemical and Clinical Effects of Vitamin E Supplementation in Hungarian Smith-Lemli-Opitz Syndrome Patients.
Biomolecules. 11 (8), 1-11, 2021.

Journal metrics:

Q2 Biochemistry
Q2 Molecular Biology
Szántó, K., Mezei, Z., Kata, D., Földesi, I., Nyári, T., Fábián, A., Rutka, M., Bor, R., Bálint, A., Milassin, Á., Szepes, Z., Nagy, F., Palatka, K., Farkas, K., Molnár, T.: Combination therapy with anti-TNFs and thiopurines does affect drug metabolite levels but it is not associated with body composition in inflammatory bowel disease patients: a cross-sectional study.
Gasztroenterol. Hepatol. Szle. 7 (4), 164-170, 2021.
Baráth, B., Kissné Bogáti, R., Miklós, T., Kállai, J., Mezei, Z., Bereczky, Z., Muszbek, L., Katona, É.: Effect of [alfa]2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
Thromb. Res. 203 110-116, 2021.

Journal metrics:

Q1 Hematology

2019

Mezei, Z., Tornai, D., Földesi, R., Madar, L., Sümegi, A., Papp, M., Antal-Szalmás, P.: A DNA pool of FLT3-ITD positive DNA samples can be used efficiently for analytical evaluation of NGS-based FLT3-ITD quantitation: testing several different ITD sequences and rates, simultaneously.
J. Biotechnol. 303 25-29, 2019.

Journal metrics:

Q1 Applied Microbiology and Biotechnology
Q2 Bioengineering
Q1 Biotechnology
Q1 Medicine (miscellaneous)
Szántó, K., Szíjártó, A., Kata, D., Földesi, I., Mezei, Z., Fábián, Á., Bálint, A., Bor, R., Farkas, K., Milassin, Á., Rutka, M., Szepes, Z., Nagy, F., Bubán, T., Lovas, S., Palatka, K., Molnár, T.: Blood thiopurine level, anti-TNF drug level and body composition parameters in inflammatory bowel diseases patients: a cross-sectional study in a Hungarian IBD centre.
J. Crohns Colitis. 13 (Supplement1), S456, 2019.

2018

Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z., Bereczky, Z.: ALPHA-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism in Patients with Venous Thromboembolism.
Proceedings. 2 (9), 102-103, 2018.
Balogh, L., Katona, É., Mezei, Z., Kállai, J., Gindele, R., Édes, I., Muszbek, L., Papp, Z., Bereczky, Z.: Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.
Mol. Cell. Biochem. 448 (1-2), 199-209, 2018.

Journal metrics:

Q3 Cell Biology
Q2 Clinical Biochemistry
Q1 Medicine (miscellaneous)
Q3 Molecular Biology
Székely, E., Czuriga-Kovács, K., Bereczky, Z., Katona, É., Mezei, Z., Nagy, A., Tóth, N., Berényi, E., Muszbek, L., Csiba, L., Bagoly, Z.: Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients.
Sci. Rep. 8 (1), 1-9, 2018.

Journal metrics:

D1 Multidisciplinary
Gindele, R., Colombo, R., Szabó, Z., Speker, M., Mezei, Z., Balogh, L., Katona, É., Bagoly, Z., Fiatal, S., Bereczky, Z.: Prevalence of Antithrombin Budapest 3 Mutation among Different Patients Groups; Investigation of the Age and Origin of Mutation Common in Hungary.
Proceedings. 2 (9), 76-77, 2018.
Kurdi, B., Mezei, Z., Kellner, Á., Egyed, M.: Thalassaemiás betegen észlelt anaemia perniciosa: a diagnózis nehézségei.
Orv. hetil. 159 (33), 1368-1371, 2018.

Journal metrics:

Q3 Medicine (miscellaneous)
Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z., Bereczky, Z.: The Effect of Alpha-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism on the Risk of Venous Thromboembolism.
Res Pract Thromb Haemost. 2 324-324, 2018.

2017

Mádi, A., Cuaranta-Monroy, I., Lénárt, K., Pap, A., Mezei, Z., Kristóf, E., Oláh, A., Vámosi, G., Bacsó, Z., Bai, P., Fésüs, L.: Browning deficiency and low mobilization of fatty acids in gonadal white adipose tissue leads to decreased cold-tolerance of transglutaminase 2 knock-out mice.
Biochim. Biophys. Acta. Mol. Cell Biol. Lipids. 1862 (12), 1575-1586, 2017.

Journal metrics:

Q1 Cell Biology
Q1 Molecular Biology
Mezei, Z., Katona, É., Kállai, J., Bereczky, Z., Somodi, L., Molnár, É., Kovács, B., Miklós, T., Ajzner, É., Muszbek, L.: Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
Thromb. Res. 158 93-97, 2017.

Journal metrics:

Q2 Hematology

2016

Mezei, Z., Katona, É., Kállai, J., Bereczky, Z., Molnár, É., Kovács, B., Ajzner, É., Bagoly, Z., Miklós, T., Muszbek, L.: Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.
Thromb. Res. 148 101-106, 2016.

Journal metrics:

Q2 Hematology

2015

Mezei, Z., Bereczky, Z., Katona, É., Gindele, R., Balogh, E., Fiatal, S., Balogh, L., Czuriga, I., Ádány, R., Édes, I., Muszbek, L.: Factor XIII B Subunit Polymorphisms and the Risk of Coronary Artery Disease.
Int. J. Mol. Sci. 16 (1), 1143-1159, 2015.

Journal metrics:

Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
Q1 Spectroscopy

2014

Shemirani, A., Antalfi, B., Pongrácz, E., Mezei, Z., Bereczky, Z., Csiki, Z.: Factor XIII-A subunit Val34Leu polymorphism in fatal atherothrombotic ischemic stroke.
Blood Coagul. Fibrinolysis. 25 (4), 364-368, 2014.

Journal metrics:

Q3 Hematology
Q2 Medicine (miscellaneous)

2013

Antalfi, B., Pongrácz, E., Csiki, Z., Mezei, Z., Shemirani, A.: Factor XIII-A subunit Val34Leu polymorphism in fatal hemorrhagic stroke.
Int. J. Lab. Hematol. 35 (1), 88-91, 2013.

Journal metrics:

Q2 Endocrinology
Q2 Endocrinology, Diabetes and Metabolism
Q1 Medicine (miscellaneous)
Q2 Orthopedics and Sports Medicine
Bagoly, Z., Székely, E., Kovács, K., Mezei, Z., Katona, É., Kappelmayer, J., Csiba, L., Muszbek, L.: The effect of factor XIII and other regulators of fibrinolysis on the outcome of thrombolysis in ischemic stroke patients.
J. Thromb. Haemost. 11 (s2), 405-406, 2013.

2012

Koncz, Z., Bagoly, Z., Haramura, G., Mezei, Z., Muszbek, L.: Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation.
Thromb. Res. 129 (4), 508-513, 2012.

Journal metrics:

Q2 Hematology

Show all

updated: 2024-11-10, 02:02